Search

Search Results
Results 1 - 10 of 330 for lentiviruses
  • News - 7 Jul 2024
    Researchers discovered that interferon-stimulated SAMD9L restricts HIV-1 and other lentiviruses by inhibiting viral translation and endosomal trafficking, while SAMD9 enhances HIV-1 replication.
  • News - 29 Jan 2024
    New off-the-shelf system reduces the cost and risk of lentiviral (LV) production for cell and gene therapy developers.
  • News - 18 Sep 2015
    CEVEC Pharmaceuticals GmbH, the expert in the production of tailor-made recombinant glycoproteins and gene therapy vectors, today announced a collaboration agreement with Généthon (Evry, France) for...
  • News - 19 Aug 2009
    Biologics contract manufacturer Omnia Biologics, Inc. (Omnia) (Rockville, MD) and drug development company Aparna Biosciences Corp. (AparnaBio) (Rockville, MD) today announced a deal for Omnia to...
  • Equipment - 5 Sep 2023
    Leprechaun is a state-of-the-art lentivirus titer and characterization platform, for contaminant analysis and much more.
  • Life Sciences - 20 Jul 2023
    Viruses that belong to the genus Lentivirus of the family Retroviridae are exogenous, have specific morphology and contain a relatively complex retroviral genome. Vectors derived from lentiviruses can...
  • Life Sciences - 20 Jul 2023
    Viruses are small obligate intracellular parasites with either a RNA or DNA genome that are surrounded by a protective protein coat and transfer their genetic material to infected cells.
  • Life Sciences - 20 Jul 2023
    Lentivirus is a genus in the family of Retroviridae that is very suitable for remodeling into gene transfer vectors due to its stable transgene expression, the ability to reach the nuclei of the...
  • Life Sciences - 20 Jul 2023
    Lentivirus genus represents a diverse, yet exceptionally cohesive group of retroviruses. Their influence on the health and general well-being of animals and humans alike has been enormous. Members of...
  • News - 30 Mar 2010
    Helmholtz Zentrum M-nchen has launched a new cooperative project with SIRION BIOTECH GmbH in Martinsried to develop new therapeutic approaches against lymphoid tumors. With a two-year grant from the...

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.